292 related items for PubMed ID: 29569191
21. Glomerular endothelial cells and podocytes can express CD80 in patients with minimal change disease during relapse.
Cara-Fuentes G, Venkatareddy M, Verma R, Segarra A, Cleuren AC, Martínez-Ramos A, Johnson RJ, Garg P.
Pediatr Nephrol; 2020 Oct; 35(10):1887-1896. PubMed ID: 32399663
[Abstract] [Full Text] [Related]
22. Incidence of remission and relapse of proteinuria, end-stage kidney disease, mortality, and major outcomes in primary nephrotic syndrome: the Japan Nephrotic Syndrome Cohort Study (JNSCS).
Yamamoto R, Imai E, Maruyama S, Yokoyama H, Sugiyama H, Nitta K, Tsukamoto T, Uchida S, Takeda A, Sato T, Wada T, Hayashi H, Akai Y, Fukunaga M, Tsuruya K, Masutani K, Konta T, Shoji T, Hiramatsu T, Goto S, Tamai H, Nishio S, Shirasaki A, Nagai K, Yamagata K, Hasegawa H, Yasuda H, Ichida S, Naruse T, Nishino T, Sobajima H, Tanaka S, Akahori T, Ito T, Terada Y, Katafuchi R, Fujimoto S, Okada H, Ishimura E, Kazama JJ, Hiromura K, Mimura T, Suzuki S, Saka Y, Sofue T, Suzuki Y, Shibagaki Y, Kitagawa K, Morozumi K, Fujita Y, Mizutani M, Shigematsu T, Kashihara N, Sato H, Matsuo S, Narita I, Isaka Y.
Clin Exp Nephrol; 2020 Jun; 24(6):526-540. PubMed ID: 32146646
[Abstract] [Full Text] [Related]
23. Diagnostic value of urinary retinol-binding protein in childhood nephrotic syndrome.
Dillon SC, Taylor GM, Shah V.
Pediatr Nephrol; 1998 Oct; 12(8):643-7. PubMed ID: 9811386
[Abstract] [Full Text] [Related]
24. Urine neutrophil gelatinase-associated lipocalin and kidney injury in children with focal segmental glomerulosclerosis.
Youssef DM, El-Shal AA.
Iran J Kidney Dis; 2012 Sep; 6(5):355-60. PubMed ID: 22976261
[Abstract] [Full Text] [Related]
25. [Nephrotic syndrome in minimal change disease (kidney), focal segmental glomerulosclerosis, and focal mesangioproliferative glomerulonephritis].
Voznesenskaia TS, Sergeeva TV.
Ter Arkh; 2002 Sep; 74(6):31-3. PubMed ID: 12136479
[Abstract] [Full Text] [Related]
26. Emerging therapeutic strategies for minimal change disease and focal and segmental glomerulosclerosis.
Siligato R, Cernaro V, Nardi C, De Gregorio F, Gembillo G, Costantino G, Conti G, Buemi M, Santoro D.
Expert Opin Investig Drugs; 2018 Nov; 27(11):839-879. PubMed ID: 30360670
[Abstract] [Full Text] [Related]
27. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M.
Pediatr Nephrol; 2016 Mar; 31(3):425-34. PubMed ID: 26335197
[Abstract] [Full Text] [Related]
28. Minimal change disease and focal segmental glomerulosclerosis in adults: response to steroids and risk of renal failure.
Moura LR, Franco MF, Kirsztajn GM.
J Bras Nefrol; 2015 Mar; 37(4):475-80. PubMed ID: 26648497
[Abstract] [Full Text] [Related]
29. Fractional excretion of IgG predicts renal outcome and response to therapy in primary focal segmental glomerulosclerosis: a pilot study.
Bazzi C, Petrini C, Rizza V, Napodano P, Paparella M, Arrigo G, Pisano L, D'Amico G.
Am J Kidney Dis; 2003 Feb; 41(2):328-35. PubMed ID: 12552493
[Abstract] [Full Text] [Related]
30. Urinary protein electrophoresis patterns in childhood idiopathic nephrotic syndrome.
Adamson O, Trachtman H, Tejani A.
Int J Pediatr Nephrol; 1986 Feb; 7(4):181-6. PubMed ID: 2434444
[Abstract] [Full Text] [Related]
31. Urinary CD80: a biomarker for a favorable response to corticosteroids in minimal change disease.
Cara-Fuentes G, Lanaspa MA, Garcia GE, Banks M, Garin EH, Johnson RJ.
Pediatr Nephrol; 2018 Jul; 33(7):1101-1103. PubMed ID: 29492674
[Abstract] [Full Text] [Related]
32. C1q nephropathy: a variant of focal segmental glomerulosclerosis.
Markowitz GS, Schwimmer JA, Stokes MB, Nasr S, Seigle RL, Valeri AM, D'Agati VD.
Kidney Int; 2003 Oct; 64(4):1232-40. PubMed ID: 12969141
[Abstract] [Full Text] [Related]
33. Nephrotic Syndrome After Hematopoietic Stem Cell Transplant: Outcomes in Iran.
Saddadi F, Alidadi A, Hakemi M, Bahar B.
Exp Clin Transplant; 2017 Feb; 15(Suppl 1):90-92. PubMed ID: 28260442
[Abstract] [Full Text] [Related]
34. Angiopoietin-like-4 and minimal change disease.
Cara-Fuentes G, Segarra A, Silva-Sanchez C, Wang H, Lanaspa MA, Johnson RJ, Garin EH.
PLoS One; 2017 Feb; 12(4):e0176198. PubMed ID: 28441404
[Abstract] [Full Text] [Related]
35. Comparative differential proteomic analysis of minimal change disease and focal segmental glomerulosclerosis.
Pérez V, López D, Boixadera E, Ibernón M, Espinal A, Bonet J, Romero R.
BMC Nephrol; 2017 Feb 03; 18(1):49. PubMed ID: 28158993
[Abstract] [Full Text] [Related]
36. Glomerular tip lesion: a distinct entity within the minimal change disease/focal segmental glomerulosclerosis spectrum.
Stokes MB, Markowitz GS, Lin J, Valeri AM, D'Agati VD.
Kidney Int; 2004 May 03; 65(5):1690-702. PubMed ID: 15086908
[Abstract] [Full Text] [Related]
37. Characterization of proteinuria in primary glomerulonephritides: urinary polymers of albumin.
Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A, D'Amico G.
Am J Kidney Dis; 1997 Sep 03; 30(3):404-12. PubMed ID: 9292570
[Abstract] [Full Text] [Related]
38. Increased urinary CD80 excretion and podocyturia in Fabry disease.
Trimarchi H, Canzonieri R, Schiel A, Costales-Collaguazo C, Politei J, Stern A, Paulero M, Rengel T, Andrews J, Forrester M, Lombi M, Pomeranz V, Iriarte R, Muryan A, Zotta E, Sanchez-Niño MD, Ortiz A.
J Transl Med; 2016 Oct 13; 14(1):289. PubMed ID: 27733175
[Abstract] [Full Text] [Related]
39. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
Am J Kidney Dis; 2009 Jul 13; 54(1):51-8. PubMed ID: 19406543
[Abstract] [Full Text] [Related]
40. CD80 expression and infiltrating regulatory T cells in idiopathic nephrotic syndrome of childhood.
Eroglu FK, Orhan D, İnözü M, Duzova A, Gulhan B, Ozaltin F, Topaloglu R.
Pediatr Int; 2019 Dec 13; 61(12):1250-1256. PubMed ID: 31513327
[Abstract] [Full Text] [Related]
Page: [Previous] [Next] [New Search]
